世界のメサラジン市場 2022年

出版:QYResearch(QYリサーチ) 出版年月:2022年8月

Global Mesalazine Market Research Report 2022
世界のメサラジン市場調査レポート 2022年

ページ数118
図表数185
価格
シングルユーザライセンスUSD 2,900
マルチユーザライセンスUSD 4,350
エンタープライズライセンスUSD 5,800
種別英文調査報告書

レポート目次  お問合せ・ご注文  価格・納期について

無料サンプル

Due to the COVID-19 pandemic, the global Mesalazine market size is estimated to be worth US$ 179.73 million in 2022 and is forecast to a readjusted size of US$ 223.48 million by 2028 with a CAGR of 3.70% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for 53.03% of the Mesalazine global market in 2021, is projected to value US$ 137.98 million by 2028, growing at a revised 6.02% CAGR from 2022 to 2028. While Tablets segment is altered to an 2.49% CAGR throughout this forecast period.
North America Mesalazine market size was US$ 18.67 million in 2021, while Europe was US$ 68.91 million. The proportion of the North America was 11.54% in 2021, while Europe’s percentage was 42.59%, and it is predicted that Europe market share will reach 40.76% in 2028, trailing a CAGR of 3.16% through the analysis period. As for the Asia, the notable markets are Japan and South Korea, CAGR is 2.64% and 2.85% respectively for the next 6-year period.
The global major manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, and Lasa Loboratory, etc. In terms of revenue, the global three largest players hold a 50.43% market share of Mesalazine in 2021.
This report focuses on Mesalazine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mesalazine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.
Global Mesalazine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Mesalazine Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Segment by Type
Purity ≥97%
Purity ≥98%
Purity ≥99%

Segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others

Consumption by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Others
Europe
Germany
France
U.K.
Italy
Russia
Others
South America
Brazil
Argentina
Others
Middle East and Africa
GCC Countries
Israel
Iran
South Africa
Others


目次

Tables and Figures

1 Mesalazine Market Overview1
1.1 Product Overview and Scope of Mesalazine1
1.2 Mesalazine Segment by Type1
1.2.1 Global Mesalazine Sales Growth Rate Comparison by Type (2022-2028)2
1.2.2 Purity ≥97%3
1.2.3 Purity ≥98%3
1.2.4 Purity ≥99%4
1.3 Mesalazine Segment by Application5
1.3.1 Global Mesalazine Sales Comparison by Application (2022-2028)5
1.3.2 Tablets6
1.3.3 Capsules7
1.3.4 Pellet and Granule7
1.3.5 Suppository8
1.3.6 Enema8
1.4 Global Mesalazine Market Size Estimates and Forecasts9
1.4.1 Global Mesalazine Revenue 2017-20289
1.4.2 Global Mesalazine Sales 2017-202810
1.4.3 Mesalazine Market Size by Region: 2017 Versus 2021 Versus 202811
2 Mesalazine Market Competition by Manufacturers12
2.1 Global Mesalazine Sales Market Share by Manufacturers (2017-2022)12
2.2 Global Mesalazine Revenue Market Share by Manufacturers (2017-2022)15
2.3 Global Mesalazine Average Price by Manufacturers (2017-2022)17
2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type18
2.5 Mesalazine Market Competitive Situation and Trends19
2.5.1 Mesalazine Market Concentration Rate19
2.5.2 The Global 5 and 10 Largest Mesalazine Players Market Share by Revenue20
2.5.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)21
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans23
3 Mesalazine Retrospective Market Scenario by Region24
3.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2017-202224
3.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2017-202225
3.3 North America Mesalazine Market Facts & Figures by Country25
3.3.1 North America Mesalazine Sales by Country25
3.3.2 North America Mesalazine Revenue by Country26
3.3.3 United States27
3.3.4 Canada28
3.3.5 Mexico28
3.4 Europe Mesalazine Market Facts & Figures by Country29
3.4.1 Europe Mesalazine Sales by Country29
3.4.2 Europe Mesalazine Revenue by Country30
3.4.3 Germany31
3.4.4 France32
3.4.5 U.K.32
3.4.6 Italy33
3.4.7 Russia33
3.5 Asia Pacific Mesalazine Market Facts & Figures by Region34
3.5.1 Asia Pacific Mesalazine Sales by Region34
3.5.2 Asia Pacific Mesalazine Revenue by Region35
3.5.3 China36
3.5.4 Japan37
3.5.5 South Korea37
3.5.6 India38
3.5.7 Australia38
3.5.8 SEA39
3.6 South America Mesalazine Market Facts & Figures by Country39
3.6.1 South America Mesalazine Sales by Country39
3.6.2 South America Mesalazine Revenue by Country40
3.6.3 Brazil41
3.6.4 Argentina41
3.7 Middle East and Africa Mesalazine Market Facts & Figures by Country42
3.7.1 Middle East and Africa Mesalazine Sales by Country42
3.7.2 Middle East and Africa Mesalazine Revenue by Country43
3.7.3 GCC Countries44
3.7.4 Israel44
3.7.5 Iran45
3.7.6 South Africa45
4 Mesalazine Historic Market Analysis by Type46
4.1 Global Mesalazine Sales Market Share by Type (2017-2022)46
4.2 Global Mesalazine Revenue Market Share by Type (2017-2022)47
4.3 Global Mesalazine Price by Type (2017-2022)47
5 Mesalazine Historic Market Analysis by Application48
5.1 Global Mesalazine Sales Market Share by Application (2017-2022)48
5.2 Global Mesalazine Revenue Market Share by Application (2017-2022)49
5.3 Global Mesalazine Price by Application (2017-2022)50
6 Key Companies Profiled51
6.1 PharmaZell51
6.1.1 PharmaZell Corporation Information51
6.1.2 PharmaZell Description and Business Overview51
6.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2017-2022)52
6.1.4 PharmaZell Mesalazine Product Portfolio52
6.2 Syntese A/S53
6.2.1 Syntese A/S Corporation Information53
6.2.2 Syntese A/S Description and Business Overview53
6.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2017-2022)54
6.2.4 Syntese A/S Mesalazine Product Portfolio54
6.3 Cambrex Corporation54
6.3.1 Cambrex Corporation Corporation Information54
6.3.2 Cambrex Corporation Description and Business Overview55
6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2017-2022)56
6.3.4 Cambrex Corporation Mesalazine Product Portfolio56
6.4 Divis Laboratories57
6.4.1 Divis Laboratories Corporation Information57
6.4.2 Divis Laboratories Description and Business Overview58
6.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2017-2022)59
6.4.4 Divis Laboratories Mesalazine Product Portfolio59
6.5 Chemi SpA59
6.5.1 Chemi SpA Corporation Information59
6.5.2 Chemi SpA Description and Business Overview60
6.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2017-2022)60
6.5.4 Chemi SpA Mesalazine Product Portfolio60
6.6 Ipca Laboratories61
6.6.1 Ipca Laboratories Corporation Information61
6.6.2 Ipca Laboratories Description and Business Overview62
6.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2017-2022)62
6.6.4 Ipca Laboratories Mesalazine Product Portfolio62
6.7 Hangzhou Brother63
6.7.1 Hangzhou Brother Corporation Information63
6.7.2 Hangzhou Brother Description and Business Overview63
6.7.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2017-2022)64
6.7.4 Hangzhou Brother Mesalazine Product Portfolio64
6.8 Lianyungang Fengheng Biopharm64
6.8.1 Lianyungang Fengheng Biopharm Corporation Information64
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview65
6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2017-2022)65
6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio66
6.9 Lasa Loboratory66
6.9.1 Lasa Loboratory Corporation Information66
6.9.2 Lasa Loboratory Description and Business Overview67
6.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2017-2022)67
6.9.4 Lasa Loboratory Mesalazine Product Portfolio67
6.10 Corden Pharma Bergamo68
6.10.1 Corden Pharma Bergamo Corporation Information68
6.10.2 Corden Pharma Bergamo Description and Business Overview69
6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2017-2022)69
6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio69
6.11 Erregierre SpA70
6.11.1 Erregierre SpA Corporation Information70
6.11.2 Erregierre SpA Description and Business Overview70
6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2017-2022)71
6.11.4 Erregierre SpA Mesalazine Product Portfolio71
6.12 CTX Lifescience71
6.12.1 CTX Lifescience Corporation Information71
6.12.2 CTX Lifescience Description and Business Overview72
6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2017-2022)72
6.12.4 CTX Lifescience Mesalazine Product Portfolio72
6.13 Ishita Active Pharma Ingredients73
6.13.1 Ishita Active Pharma Ingredients Corporation Information73
6.13.2 Ishita Active Pharma Ingredients Description and Business Overview73
6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2017-2022)74
6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio74
6.14 YC Biotech (Jiangsu)74
6.14.1 YC Biotech (Jiangsu) Corporation Information74
6.14.2 YC Biotech (Jiangsu) Description and Business Overview75
6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2017-2022)76
6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio76
6.15 Xinxiang Tianfeng Fine Chemical76
6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information76
6.15.2 Xinxiang Tianfeng Fine Chemical Description and Business Overview77
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2017-2022)77
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio78
7 Mesalazine Manufacturing Cost Analysis79
7.1 Mesalazine Key Raw Materials Analysis79
7.1.1 Key Raw Materials79
7.1.2 Key Suppliers of Raw Materials79
7.2 Manufacturing Process Analysis of Mesalazine80
7.3 Mesalazine Industrial Chain Analysis80
8 Marketing Channel, Distributors and Customers81
8.1 Marketing Channel81
8.2 Mesalazine Distributors List82
8.3 Mesalazine Customers83
9 Mesalazine Market Dynamics84
9.1 Mesalazine Industry Trends84
9.2 Mesalazine Market Drivers84
9.3 Mesalazine Market Challenges86
10 Global Market Forecast87
10.1 Mesalazine Market Estimates and Projections by Type87
10.1.1 Global Forecasted Sales of Mesalazine by Type (2023-2028)87
10.1.2 Global Forecasted Revenue of Mesalazine by Type (2023-2028)87
10.2 Mesalazine Market Estimates and Projections by Application88
10.2.1 Global Forecasted Sales of Mesalazine by Application (2023-2028)88
10.2.2 Global Forecasted Revenue of Mesalazine by Application (2023-2028)89
10.3 Mesalazine Market Estimates and Projections by Region90
10.3.1 Global Forecasted Sales of Mesalazine by Region (2023-2028)90
10.3.2 Global Forecasted Revenue of Mesalazine by Region (2023-2028)90
11 Research Findings and Conclusion92
12 Methodology and Data Source93
12.1 Methodology/Research Approach93
12.1.1 Research Programs/Design93
12.1.2 Market Size Estimation94
12.1.3 Market Breakdown and Data Triangulation95
12.2 Data Source96
12.2.1 Secondary Sources96
12.2.2 Primary Sources97
12.3 Author List99
12.4 Disclaimer99

Table 1. Global Mesalazine Sales Growth Rate Comparison by Type (2022-2028) & (Tons) & (US$ Million)2
Table 2. Major Manufacturers of Purity ≥97%3
Table 3. Major Manufacturers of Purity ≥98%3
Table 4. Major Manufacturers of Purity ≥99%4
Table 5. Global Mesalazine Sales Growth Rate Comparison by Application (2022-2028) & (Tons) & (US$ Million)5
Table 6. Global Mesalazine Market Size by Region (US$ Million): 2017 VS 2021 VS 202811
Table 7. Global Mesalazine Market Competitive Situation by Manufacturers in 202112
Table 8. Global Mesalazine Sales (Tons) of Key Manufacturers (2017-2022)13
Table 9. Global Mesalazine Sales Market Share by Manufacturers (2017-2022)13
Table 10. Global Mesalazine Revenue (US$ Million) by Manufacturers (2017-2022)15
Table 11. Global Mesalazine Revenue Share by Manufacturers (2017-2022)15
Table 12. Global Market Mesalazine Average Price (US$/Kg) of Key Manufacturers (2017-2022)17
Table 13. Manufacturers Mesalazine Manufacturing Sites and Area Served18
Table 14. Manufacturers Mesalazine Product Type18
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)20
Table 16. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2021)21
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans23
Table 18. Global Mesalazine Sales by Region (2017-2022) & (Tons)24
Table 19. Global Mesalazine Sales Market Share by Region (2017-2022)24
Table 20. Global Mesalazine Revenue by Region (2017-2022) & (US$ Million)25
Table 21. Global Mesalazine Revenue Market Share by Region (2017-2022)25
Table 22. North America Mesalazine Sales by Country (2017-2022) & (Tons)25
Table 23. North America Mesalazine Sales Market Share by Country (2017-2022)26
Table 24. North America Mesalazine Revenue by Country (2017-2022) & (US$ Million)26
Table 25. North America Mesalazine Revenue Market Share by Country (2017-2022)27
Table 26. Europe Mesalazine Sales by Country (2017-2022) & (Tons)29
Table 27. Europe Mesalazine Sales Market Share by Country (2017-2022)29
Table 28. Europe Mesalazine Revenue by Country (2017-2022) & (US$ Million)30
Table 29. Europe Mesalazine Revenue Market Share by Country (2017-2022)30
Table 30. Asia Pacific Mesalazine Sales by Region (2017-2022) & (Tons)34
Table 31. Asia Pacific Mesalazine Sales Market Share by Region (2017-2022)34
Table 32. Asia Pacific Mesalazine Revenue by Region (2017-2022) & (US$ Million)35
Table 33. Asia Pacific Mesalazine Revenue Market Share by Region (2017-2022)35
Table 34. South America Mesalazine Sales by Country (2017-2022) & (Tons)39
Table 35. South America Mesalazine Sales Market Share by Country (2017-2022)39
Table 36. South America Mesalazine Revenue by Country (2017-2022) & (US$ Million)40
Table 37. South America Mesalazine Revenue Market Share by Country (2017-2022)40
Table 38. Middle East and Africa Mesalazine Sales by Country (2017-2022) & (Tons)42
Table 39. Middle East and Africa Mesalazine Sales Market Share by Country (2017-2022)42
Table 40. Middle East and Africa Mesalazine Revenue by Country (2017-2022) & (US$ Million)43
Table 41. Middle East and Africa Mesalazine Revenue Market Share by Country (2017-2022)43
Table 42. Global Mesalazine Sales by Type (2017-2022) & (Tons)46
Table 43. Global Mesalazine Sales Market Share by Type (2017-2022)46
Table 44. Global Mesalazine Revenue by Type (2017-2022) & (US$ Million)47
Table 45. Global Mesalazine Revenue Share by Type (2017-2022)47
Table 46. Global Mesalazine Price by Type (2017-2022) & (US$/Kg)47
Table 47. Global Mesalazine Sales (Tons) by Application (2017-2022)48
Table 48. Global Mesalazine Sales Market Share by Application (2017-2022)48
Table 49. Global Mesalazine Revenue by Application (2017-2022) & (US$ Million)49
Table 50. Global Mesalazine Revenue Share by Application (2017-2022)50
Table 51. Global Mesalazine Price by Application (2017-2022) & (US$/Kg)50
Table 52. PharmaZell Corporation Information51
Table 53. PharmaZell Description and Business Overview51
Table 54. PharmaZell Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)52
Table 55. PharmaZell Mesalazine Product52
Table 56. Syntese A/S Corporation Information53
Table 57. Syntese A/S Description and Business Overview53
Table 58. Syntese A/S Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)54
Table 59. Syntese A/S Mesalazine Product54
Table 60. Cambrex Corporation Corporation Information54
Table 61. Cambrex Corporation Description and Business Overview55
Table 62. Cambrex Corporation Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)56
Table 63. Cambrex Corporation Mesalazine Product56
Table 64. Divis Laboratories Corporation Information57
Table 65. Divis Laboratories Description and Business Overview58
Table 66. Divis Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)59
Table 67. Divis Laboratories Mesalazine Product59
Table 68. Chemi SpA Corporation Information59
Table 69. Chemi SpA Description and Business Overview60
Table 70. Chemi SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)60
Table 71. Chemi SpA Mesalazine Product60
Table 72. Ipca Laboratories Corporation Information61
Table 73. Ipca Laboratories Description and Business Overview62
Table 74. Ipca Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)62
Table 75. Ipca Laboratories Mesalazine Product62
Table 76. Hangzhou Brother Corporation Information63
Table 77. Hangzhou Brother Description and Business Overview63
Table 78. Hangzhou Brother Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)64
Table 79. Hangzhou Brother Mesalazine Product64
Table 80. Lianyungang Fengheng Biopharm Corporation Information64
Table 81. Lianyungang Fengheng Biopharm Description and Business Overview65
Table 82. Lianyungang Fengheng Biopharm Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)65
Table 83. Lianyungang Fengheng Biopharm Mesalazine Product66
Table 84. Lasa Loboratory Corporation Information66
Table 85. Lasa Loboratory Description and Business Overview67
Table 86. Lasa Loboratory Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)67
Table 87. Lasa Loboratory Mesalazine Product67
Table 88. Corden Pharma Bergamo Corporation Information68
Table 89. Corden Pharma Bergamo Description and Business Overview69
Table 90. Corden Pharma Bergamo Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)69
Table 91. Corden Pharma Bergamo Mesalazine Product69
Table 92. Erregierre SpA Corporation Information70
Table 93. Erregierre SpA Description and Business Overview70
Table 94. Erregierre SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)71
Table 95. Erregierre SpA Mesalazine Product71
Table 96. CTX Lifescience Corporation Information71
Table 97. CTX Lifescience Description and Business Overview72
Table 98. CTX Lifescience Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)72
Table 99. CTX Lifescience Mesalazine Product72
Table 100. Ishita Active Pharma Ingredients Corporation Information73
Table 101. Ishita Active Pharma Ingredients Description and Business Overview73
Table 102. Ishita Active Pharma Ingredients Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)74
Table 103. Ishita Active Pharma Ingredients Mesalazine Product74
Table 104. YC Biotech (Jiangsu) Corporation Information74
Table 105. YC Biotech (Jiangsu) Description and Business Overview75
Table 106. YC Biotech (Jiangsu) Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)76
Table 107. YC Biotech (Jiangsu) Mesalazine Product76
Table 108. Xinxiang Tianfeng Fine Chemical Corporation Information76
Table 109. Xinxiang Tianfeng Fine Chemical Description and Business Overview77
Table 110. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)77
Table 111. Xinxiang Tianfeng Fine Chemical Mesalazine Product78
Table 112. Production Base and Market Concentration Rate of Raw Material79
Table 113. Key Suppliers of Raw Materials79
Table 114. Mesalazine Distributors List82
Table 115. Mesalazine Customers List83
Table 116. Mesalazine Market Trends84
Table 117. Mesalazine Market Opportunities84
Table 118. Mesalazine Market Drivers85
Table 119. Mesalazine Market Challenges86
Table 120. Global Mesalazine Sales Forecast by Type (2023-2028) & (Tons)87
Table 121. Global Mesalazine Sales Market Share Forecast by Type (2023-2028)87
Table 122. Global Mesalazine Revenue Forecast by Type (2023-2028) & (US$ Million)87
Table 123. Global Mesalazine Revenue Market Share Forecast by Type (2023-2028)88
Table 124. Global Mesalazine Sales Forecast by Application (2023-2028) & (Tons)88
Table 125. Global Mesalazine Sales Market Share Forecast by Application (2023-2028)88
Table 126. Global Mesalazine Revenue Forecast by Application (2023-2028) & (US$ Million)89
Table 127. Global Mesalazine Revenue Market Share Forecast by Application (2023-2028)89
Table 128. Global Mesalazine Sales Forecast by Region (2023-2028) & (Tons)90
Table 129. Global Mesalazine Sales Market Share Forecast by Region (2023-2028)90
Table 130. Global Mesalazine Revenue Forecast by Region (2023-2028) & (US$ Million)90
Table 131. Global Mesalazine Revenue Market Share Forecast by Region (2023-2028)91
Table 132. Research Programs/Design for This Report93
Table 133. Key Data Information from Secondary Sources97
Table 134. Key Data Information from Primary Sources98

List of Figures

Figure 1. Product Picture of Mesalazine1
Figure 2. Global Mesalazine Market Share by Type: 2022 & 20282
Figure 3. Global Mesalazine Market Share by Application: 2022 & 20286
Figure 4. Tablets6
Figure 5. Capsules7
Figure 6. Pellet and Granule7
Figure 7. Suppository8
Figure 8. Enema8
Figure 9. Global Mesalazine Revenue, (US$ Million), 2017 VS 2021 VS 20289
Figure 10. Global Mesalazine Market Size (2017-2028) & (US$ Million)10
Figure 11. Global Mesalazine Sales (2017-2028) & (Tons)10
Figure 12. Global Mesalazine Market Size by Region (US$ Million): 2017 VS 2021 VS 202811
Figure 13. Mesalazine Sales Share by Manufacturers in 202114
Figure 14. Global Mesalazine Revenue Share by Manufacturers in 202116
Figure 15. Global 5 Largest Mesalazine Players: Market Share by Revenue in Mesalazine in 202120
Figure 16. Global 10 Largest Mesalazine Players: Market Share by Revenue in Mesalazine in 202121
Figure 17. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 202122
Figure 18. North America Mesalazine Sales Market Share by Country in 202126
Figure 19. United States Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)27
Figure 20. Canada Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)28
Figure 21. Mexico Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)28
Figure 22. Europe Mesalazine Sales Market Share by Country in 202130
Figure 23. Germany Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)31
Figure 24. France Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)32
Figure 25. U.K. Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)32
Figure 26. Italy Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)33
Figure 27. Russia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)33
Figure 28. Asia Pacific Mesalazine Sales Market Share by Country in 202135
Figure 29. China Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)36
Figure 30. Japan Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)37
Figure 31. South Korea Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)37
Figure 32. India Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)38
Figure 33. Australia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)38
Figure 34. SEA Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)39
Figure 35. South America Mesalazine Sales Market Share by Country in 202140
Figure 36. Brazil Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)41
Figure 37. Argentina Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)41
Figure 38. Middle East and Africa Mesalazine Sales Market Share by Country in 202143
Figure 39. GCC Countries Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)44
Figure 40. Israel Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)44
Figure 41. Iran Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)45
Figure 42. South Africa Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)45
Figure 43. Sales Market Share of Mesalazine by Type (2017-2022)46
Figure 44. Sales Market Share of Mesalazine by Application (2017-2022)49
Figure 45. Manufacturing Process Analysis of Mesalazine80
Figure 46. Mesalazine Industrial Chain Analysis80
Figure 47. Channels of Distribution81
Figure 48. Distributors Profiles82
Figure 49. Bottom-up and Top-down Approaches for This Report95
Figure 50. Data Triangulation96
Figure 51. Key Executives Interviewed98


    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com